Lung Cancer Clinical Trials

Showing 1161-1180 of 3,692 trials

Digital Lifestyle Intervention for Lung Cancer Survivors

NCT05819346

The aim of this study is to assess the efficacy of a digital lifestyle intervention in non-small cell lung cancer (NSCLC) survivors on health-related quality of life (HRQoL) over three months.

Non-Small Cell Lung Cancer (NSCLC)

Kai-Uwe Schmitt, PhD, MEng, ICID88 participantsStarted Aug 2023

Barmelweid, Switzerland • Davos, Switzerland • Heiligenschwendi, Switzerland +1 more locations

Active Not RecruitingPhase 2

Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD)

NCT03944772

Phase 2 Platform Study in Patients with Advanced Non-Small Lung Cancer who progressed on First-Line Osimertinib Therapy. This study is modular in design, allowing evaluation of the efficacy, safety and tolerability of multiple study treatments.

Non-Small Cell Lung Cancer

AstraZeneca247 participantsStarted Jun 2019

Duarte, California, United States • Los Angeles, California, United States • Sacramento, California, United States +44 more locations

Digital Lifestyle Intervention for Lung Cancer Survivors

Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD)

Related Searches

Evaluation of the Use of the FUR to Quantify Tumor Glucose Consumption in Oncologic PET

Osimertinib (AZD9291) in First-line Locally Advanced or Metastatic NSCLC Patients With EGFR and EGFR T790M

Evaluation of a Pragmatic Approach to Adoptive Cell Therapy (ACT) Using an IL2 Analog (ANV419) vs High Dose IL2 After Tumor Infiltrating Lymphocytes (TIL) Therapy in Patients With Melanoma, NSCLC and Cervical Cancer (PragmaTIL)

A Phase 1 Study of BPI-371153 in Subjects with Advanced Solid Tumors or Relapsed/Refractory Lymphoma

Evaluating Modifiable Biomarkers for the Prediction of Immunotherapy Response and Toxicity

Nanocrystalline Megestrol + Immunochemo As 1st-Line for ES-SCLC Cachexia

A Study of AL8326 in Non-Small Cell Lung Cancer

Investigating the Biomarkers in Tumor and Peripheral Blood to Evaluate the Efficacy of Cancer Immunotherapy in Chest Cancer Patients

ProSight: a Multi-centre Interventional Study Evaluating MCED in Asymptomatic Population

Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer

F-18 FDG PET/CT and CT in Initial Staging of Non-small Lung Cancer

AI-HOPE Lung Cancer: Building a Predictive Tool for Metastatic Lung Cancer

Nintedanib Plus EGFR TKI In EGFR-mutated Non-small Cell Lung Cancer Patients

Standard Care With or Without Early Palliative Care Provided by Palliative Care Specialist in Advanced Non-small Cell Lung Cancer Patients

Real-world Study of Sunvozertinib Treatment in Advanced EGFR-Mutant NSCLC After EGFR-TKI Treatment Failure

Keynatinib in Treated Patients With NSCLC and Brain Metastases

Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation

Efficacy and Safety of Ensartinib in Neoadjuvant Therapy for Stage IIA - IIIB (Operable or Potentially Operable) ALK-Positive Lung Adenocarcinoma ：A Multicenter, Real-World Clinical Study